+ All Categories
Home > Documents > anestesi umum

anestesi umum

Date post: 28-Nov-2014
Category:
Upload: yosef-anggoro-dibyo-prabowo
View: 812 times
Download: 1 times
Share this document with a friend
Popular Tags:
60
BAB II ANESTESI UMUM In the name of Allah SWT, the author want to say thanks to God, because only God help I can finished my paper which have a title “THE CORRELATION BETWEEN HIGH BLOOD PRESSURE AND OBESITY FOR CHILDREN AT THE AGE OF 10 IN SOUTH JAKARTA IN 2005” on time and without matter problem. This report made for completed the order of lecture English II in the Faculty of Medicine Trisakti University Jakarta. In this case the author would say a million thanks to my family for their pray and support, to Mrs.Tanti who had given a chance and guide to do this paper, and to all my friends for their help on everything. This paper is study about High Blood Pressure, Obesity, and their correlation. And hopefully this paper can be useful to whoever read. For sure the author need developed critics and suggestions for the author reports in the future can be better. Jakarta, June 2008 Bathari Pradnyaparamitha Author 1
Transcript
Page 1: anestesi umum

BAB II

ANESTESI UMUM

In the name of Allah SWT, the author want to say thanks to God, because only God

help I can finished my paper which have a title “THE CORRELATION BETWEEN HIGH

BLOOD PRESSURE AND OBESITY FOR CHILDREN AT THE AGE OF 10 IN

SOUTH JAKARTA IN 2005” on time and without matter problem.

This report made for completed the order of lecture English II in the Faculty of

Medicine Trisakti University Jakarta.

In this case the author would say a million thanks to my family for their pray and

support, to Mrs.Tanti who had given a chance and guide to do this paper, and to all my

friends for their help on everything.

This paper is study about High Blood Pressure, Obesity, and their correlation. And

hopefully this paper can be useful to whoever read. For sure the author need developed

critics and suggestions for the author reports in the future can be better.

Jakarta, June 2008

Bathari Pradnyaparamitha

Author

1

Page 2: anestesi umum

TABLE OF CONTENTS

Preface …………………………………………………………………………1

Table of Contents ……………………………………………………………...2

Chapter 1 – Introduction

1.1. Background ……………………………………………………….4

1.2. Problem …………………………………………………………...4

1.3. Limitation of Problems …………………………………………...5

1.4. Objectives ………………………………………………………...6

1.5. Methods of Writing ……………………………………………….6

1.6. Frame of Writing …………………………………………………6

Chapter 2 – High Blood Pressure

2.1. Definition …………………………………………………………8

2.2. Etiology …………………………………………………………...9

2.3. Epidemiology …………………………………………………….11

2.4. Histopathology …………………………………………………...12

2.5. Symptomatology …………………………………………………13

2.6. Diagnosis ………………………………………………………...14

2.7. Therapy …………………………………………………………..16

2.8. Treatment ………………………………………………………...17

2.9. Complication ……………………………………………………..18

2.10. Prevention …………………………………………………….19

Chapter 3 – Obesity

3.1. Definition ………………………………………………………..20

3.2. Etiology ………………………………………………………….20

3.3. Epidemiology ……………………………………………………23

3.4. Symptomatology ………………………………………………...23

3.5. Diagnosis ………………………………………………………...24

3.6. Therapy …………………………………………………………..25

3.7. Treatment ………………………………………………………...26

2

Page 3: anestesi umum

3.8. Complication ……………………………………………………..27

3.9. Prevention …………………………………………………….31

Chapter 4 - The Correlation Between High Blood Pressure and Obesity for Children at the

Age of 10 in South Jakarta in 2005

4.1. Cases ………………………………………………………….32

4.2. Pathology ……………………………………………………..32

4.3. Diagnosis ……………………………………………………..34

4.4. Treatment ……………………………………………………..34

Chapter 5- Conclusion …………………………………………………….37

Bibliography ………………………………………………………………38

3

Page 4: anestesi umum

CHAPTER I

INTRODUCTION

1.1 DEFINISI

Anestesi umum adalah tindakan meniadakan nyeri sentral disertai hilangnya

kesadaran yang bersifat reversibel. Dengan anestesi umum akan diperoleh trias

anestesia, yaitu:2

Hipnotik (tidur)

Analgesia (bebas dari nyeri)

Relaksasi otot (mengurangi ketegangan tonus otot)

Hanya eter yang memiliki trias anestesia. Karena anestesi modern saat ini

menggunakan obat-obat selain eter, maka anestesi diperoleh dengan menggabungkan

berbagai macam obat.

1.2 METODE ANESTESI UMUM 2

I. Parenteral

Anestesia umum yang diberikan secara parenteral baik intravena maupun

intramuskular biasanya digunakan untuk tindakan yang singkat atau untuk

induksi anestesia.

II. Perektal

Metode ini sering digunakan pada anak, terutama untuk induksi anestesia

maupun tindakan singkat.

III. Perinhalasi

Yaitu menggunakan gas atau cairan anestetika yang mudah menguap (volatile

agent) dan diberikan dengan O2. Konsentrasi zat anestetika tersebut

tergantunug dari tekanan parsialnya; zat anestetika disebut kuat apabila dengan

tekanan parsial yang rendah sudah mampu memberikan anestesia yang adekuat.

1.3 FAKTOR-FAKTOR YANG MEMPENGARUHI ANESTESI UMUM 2

A. Faktor Respirasi

Hal-hal yang mempengaruhi tekanan parsial zat anestetika dalam alveolus

adalah:

1. Konsentrasi zat anestetika yang diinhalasi; semakin tinggi konsentrasi, semakin

cepat kenaikan tekanan parsial

4

Page 5: anestesi umum

2. Ventilasi alveolus; semakin tinggi ventilasi, semakin cepat kenaikan tekanan

parsial

B. Faktor Sirkulasi

Saat induksi, konsentrasi zat anestetika dalam darah arterial lebih besar

daripada darah vena. Faktor yang mempengaruhinya adalah:

Perubahan tekanan parsial zat anestetika yang jenuh dalam alveolus dan darah

vena. Dalam sirkulasi, sebagian zat anestetika diserap jaringan dan sebagian

kembali melalui vena.

Koefisien partisi darah/gas yaitu rasio konsentrasi zat anestetika dalam darah

terhadap konsentrasi dalam gas setelah keduanya dalam keadaan seimbang.

Aliran darah, yaitu aliran darah paru dan curah jantung.

C. Faktor Jaringan

Perbedaan tekanan parsial obat anestetika antara darah arteri dan jaringan

Koefisien partisi jaringan/darah

Aliran darah dalam masing-masing 4 kelompok jaringan (jaringan kaya

pembuluh darah/JKPD, kelompok intermediate, lemak, dan jaringan sedikit

pembuluh darah/JSPD)

D. Faktor Zat Anestetika

Potensi dari berbagai macam obat anestetika ditentukan oleh MAC

(Minimal Alveolus Concentration), yaitu konsentrasi terendah zat anestetika dalam

udara alveolus yang mampu mencegah terjadinya tanggapan (respon) terhadap

rangsang rasa sakit. Semakin rendah nilai MAC, semakin poten zat anestetika

tersebut.

E. Faktor Lain

Ventilasi, semakin besar ventilasi, semakin cepat pendalaman anestesi

Curah jantung, semakin tinggi curah jantung, semakin lambat induksi dan

pendalaman anestesia

Suhu, semakin turun suhu, semakin larut zat anestesia sehingga pendalaman

anestesia semakin cepat.

1.4 STADIUM ANESTESI UMUM

Obesity is a common problem in much of the western world today in that is linked

directly with several disease processes, notably, hypertension. It is becoming clear that the

adipocyte is not merely an inert organ for storage of energy but that it also secretes a host

5

Page 6: anestesi umum

of factors that interact with each other and may result in elevated blood pressure. Of

particular importance is the putative role of leptin in the causation of hypertension via an

activation of the sympathetic nervous system and a direct effect on the kidneys, resulting in

increased sodium reabsorption leading to hypertension. Obesity per se may have structural

effects on the kidneys that may perpetuate hypertension, leading to an increased incidence

of end-stage renal disease that results in further hypertension. Adipose tissue may elaborate

angiotensin from its own local renin-angiotensin system. The distribution of body fat is

considered important in the genesis of the obesity-hypertension syndrome, with a

predominantly central distribution being particularly ominous. Weight loss is the

cornerstone in the management of the obesity-hypertension syndrome. It may be achieved

with diet, exercise, medications, and a combination of these measures. Anti-obesity

medications that are currently undergoing clinical trials may play a promising role in the

management of obesity and may also result in lowering of blood pressure.

Antihypertensives are considered important components in the holistic approach to the

management of this complex problem.

1.5 Problem

The prevalence of overweight and obesity in Jakarta makes obesity a leading public

health problem. Jakarta has the highest rates of obesity in the Indonesia. From 1980 to

2002, obesity has doubled in adults and overweight prevalence has tripled in children and

adolescents. From 2004-2007, 32.2% of adults aged 20 years or older were obese. The

prevalence in the Jakarta continues to rise. The prevalence of obesity has been continually

rising for two decades. This sudden rise in obesity prevalence is attributed to

environmental and population factors rather than individual behavior and biology because

of the rapid and continual rise in the number of overweight and obese individuals. The

current environment produces risk factors for decreased physical activity and for increased

calorie consumption. These environmental factors operate on the population to decrease

physical activity and increase calorie consumption.

Since most developed countries have an ageing population, the prevalence of

hypertension is increasing. This age-driven increase in cardiovascular risk is an important

factor contributing to the increasing burden of mortality and morbidity associated with

cardiovascular disease. Today, there is a strong rationale for an aggressive approach to

6

Page 7: anestesi umum

hypertension since antihypertensive treatment has been shown to reduce cardiovascular

mortality and morbidity in the elderly. It is likely that increasing emphasis will be placed

on control of isolated and borderline systolic hypertension, which are the predominant

forms of hypertension in elderly patients. The recent second Swedish Trial in Old Patients

with Hypertension (STOP-Hypertension-2) represents an important contribution to the

literature since it shows that newer antihypertensive agents, such as angiotensin converting

enzyme (ACE) inhibitors and calcium antagonists, are as effective as older agents in

reducing cardiovascular mortality and morbidity in elderly patients.

1.6 Limitation of Problems

What is high blood pressure ?

What are the signs and symptoms of high blood pressure ?

What causes high blood pressure?

What are the risk factors of high blood pressure?

How to diagnose high blood pressure?

What are complications of high blood pressure?

How are high blood pressure treated ?

How to prevent high blood pressure?

What are over obesity ?

What causes obesity ?

What are the health risks of obesity ?

What are the signs and symptoms of obesity ?

How are obesity diagnosed ?

How are obesity treated ?

How can obesity be prevented ?

1.7 Objective

To explain about high blood pressure

To give information about the causes of high blood pressure

To give information about the signs, symptoms and diagnosis of high blood

pressure

To give information about the complications of high blood pressure

7

Page 8: anestesi umum

To give information about the treatment for high blood pressure

To give information about obesity

To give information about the causes of obesity

To explain about the health risks of obesity

To give information about the signs, symptoms and diagnosis of obesity

To give information about the treatments for obesity

1.8 Methods of Writing

I get the information and data from some books to complete this paper.

Beside that, I get the other information for my paper from some websites on the

internet.

1.9 Frame of Writing

PREFACE

CONTENTS

CHAPTER 1 – INTRODUCTION

1.1 Background

1.2 Problems

1.3 Limitation of problems

1.4 Objectives

1.5 Method of writing

1.6 Frame of writing

CHAPTER 2 – HIGH BLOOD PRESSURE

2.1 Definition

2.2 Etiology

2.3 Epidemiology

2.4 Histopathology

2.5 Symptomatology

2.6 Diagnosis

2.7 Therapy

2.8 Treatment

2.9. Complication

8

Page 9: anestesi umum

2.10. Prevention

CHAPTER 3 – OBESITY

3.1 Definition

3.2 Etiology

3.3. Epidemiology

3.4 Symtomatology

3.5. Diagnosis

3.6. Therapy

3.7. Treatment

3.8. Complication

3.9. Prevention

CHAPTER 4 – THE CORRELATION BETWEEN HIGH BLOOD PRESSURE AND

OBESITY FOR CHILDREN AT THE AGE OF 10 IN SOUTH JAKARTA IN 2005

4.1. Cases

4.2. Pathology

4.3. Diagnosis

4.4. Treatment

CHAPTER 5 – CONCLUSION

BIBLIOGRAPHY

CHAPTER 2

HIGH BLOOD PRESSURE

2.1. Definition

High blood pressure (hbp) or hypertension means high pressure (tension) in the

arteries. Arteries are vessels that carry blood from the pumping heart to all the tissues and

organs of the body. High blood pressure does not mean excessive emotional tension,

although emotional tension and stress can temporarily increase blood pressure. Normal

blood pressure is below 120/80; blood pressure between 120/80 and 139/89 is called "pre-

hypertension", and a blood pressure of 140/90 or above is considered high.

9

Page 10: anestesi umum

The top number, the systolic blood pressure, corresponds to the pressure in the

arteries as the heart contracts and pumps blood forward into the arteries. The bottom

number, the diastolic pressure, represents the pressure in the arteries as the heart relaxes

after the contraction. The diastolic pressure reflects the lowest pressure to which the

arteries are exposed.

An elevation of the systolic and/or diastolic blood pressure increases the risk of

developing heart (cardiac) disease, kidney (renal) disease, hardening of the arteries

(atherosclerosis or arteriosclerosis), eye damage, and stroke (brain damage). These

complications of hypertension are often referred to as end-organ damage because damage

to these organs is the end result of chronic (long duration) high blood pressure. For that

reason, the diagnosis of high blood pressure is important so efforts can be made to

normalize blood pressure and prevent complications.

Hypertension is classified as either primary (or essential) hypertension or secondary

hypertension. Primary hypertension has no specific origin but is strongly associated with

lifestyle. It is responsible for 90 to 95 percent of diagnosed hypertension and is treated with

stress management, changes in diet, increased physical activity, and medication (if

needed). Secondary hypertension is responsible for 5 to 10 percent of diagnosed

hypertension. It is caused by a preexisting medical condition such as congestive heart

failure, kidney failure, liver failure, or damage to the endocrine (hormone) system.

Pregnancy-induced hypertension (PIH) may appear in otherwise healthy women

after the twentieth week of pregnancy. It is more likely to occur in women who are

overweight or obese. PIH may be mild or severe, and it is accompanied by water retention

and protein in the urine. About 5 percent of PIH cases progress to preeclampsia.

Preeclampsia is characterized by dizziness, headache, visual disturbance, abdominal pain,

facial edema, poor appetite, nausea, and vomiting. Severe preeclampsia affects the

mother's blood system, kidneys, brain, and other organs. In rare cases, the woman can die.

Preeclampsia is more likely to occur during first pregnancies, multiple fetuses, in women

with existing hypertension, and in women younger than twenty-five years old or over

thirty-five years old. If convulsions occur with PIH, it is called eclampsia. PIH disappears

within a few weeks after birth

10

Page 11: anestesi umum

2.2 Etiology

The causes of high blood pressure are complex. Obesity has long been recognised

to be a major determinant of blood pressure. Obesity is largely determined by an

interaction between diet (calorie intake) and exercise (calorie consumption). Diet also has

direct effects on blood pressure, largely mediated through Na+ intake. Exercise may have

direct effects on blood pressure. There is evidence from primate studies that social status

affects blood pressure through its link to chronic stress exposure. Two forms of high blood

pressure have been described: essential (or primary) hypertension and secondary

hypertension. Essential hypertension is a far more common condition and accounts for

95% of hypertension. The cause of essential hypertension is multifactorial, that is, there are

several factors whose combined effects produce hypertension. In secondary hypertension,

which accounts for 5% of hypertension, the high blood pressure is secondary to (caused

by) a specific abnormality in one of the organs or systems of the body.

Genetic factors are thought to play a prominent role in the development of essential

hypertension. However, the genes for hypertension have not yet been identified. (Genes are

tiny portions of chromosomes that produce the proteins that determine the characteristics

of individuals.) The current research in this area is focused on the genetic factors that affect

the renin-angiotensin-aldosterone system. This system helps to regulate blood pressure by

controlling salt balance and the tone (state of elasticity) of the arteries. Rarely, certain

unusual genetic disorders affecting the hormones of the adrenal glands may lead to

hypertension. (These identified genetic disorders are actually considered secondary

hypertension.)

The vast majority of patients with essential hypertension have in common a

particular abnormality of the arteries: an increased resistance (stiffness or lack of elasticity)

in the tiny arteries that are most distant from the heart (peripheral arteries or arterioles).

The arterioles supply oxygen-containing blood and nutrients to all of the tissues of the

body. The arterioles are connected by capillaries in the tissues to the veins (the venous

system), which returns the blood to the heart and lungs. Just what makes the peripheral

arteries become stiff is not known. Yet, this increased peripheral arteriolar stiffness is

present in those individuals whose essential hypertension is associated with genetic factors,

obesity, lack of exercise, overuse of salt, and aging. Inflammation also may play a role in

hypertension since a predictor of the development of hypertension is the presence of an

11

Page 12: anestesi umum

elevated C reactive protein level (a blood test marker of inflammation) in some individuals.

Risk factors for hypertension include:

- age over 60

- male sex

- race

- heredity

- salt sensitivity

- obesity

- inactive lifestyle

- heavy alcohol consumption

- use of oral contraceptives

2.3. Epidemiology

The prevalence of hypertension differs among racial and ethnic groups compared

with the general population. For example, American Indians have the same prevalence as,

or a higher prevalence than, the general population; among Hispanics, blood pressure is

generally the same as or lower than that of non-Hispanic whites, despite a high prevalence

of obesity and type 2 diabetes mellitus. It also appears that South Asians are more

responsive to various antihypertensive medications than whites. Evidence shows that

hypertension awareness, treatment, and control in some groups, especially those with

generally lower socioeconomic status, require more focused hypertension education and

intervention programs.

The prevalence of hypertension in African Americans is among the highest in the

world. Compared with whites, hypertension develops earlier in life and average blood

pressures are much higher in African Americans. African Americans have higher rates of

stage 3 hypertension than whites, causing a greater burden of hypertension complications.

12

Page 13: anestesi umum

This earlier onset, higher prevalence, and greater rate of stage 3 hypertension in African

Americans is accompanied by an 80-percent higher stroke mortality rate, a 50-percent

higher heart disease mortality rate, and a 320-percent greater rate of hypertension-related

end-stage renal disease than seen in the general population.

A new study on risk factors in cardiovascular disease in Asia has found that blood

pressure is more strongly related to coronary heart disease and stroke in Asia, as compared

with Western countries such as Australia and New Zealand.

A paper from the George Institute for International Health on the outcomes of the

study, to be published in the October 2005 issue of the European Journal of Cardiovascular

Prevention and Rehabilitation, notes that high blood pressure is a key risk factor for

haemorrhagic stroke, which is relatively more common amongst Asian populations. A

10mmHg increase in systolic blood pressure was found to be associated with a 72% greater

risk of having a haemorrhagic stroke in Asian groups, compared with 49% in Australia and

New Zealand.

Recent data suggest that hypertension (high blood pressure) is higher in many

Asian countries than in Australia. For example, around 28% of people in China are

estimated to have hypertension, compared with 19% in Australia. In India and Japan, the

percentages are higher still.

2.4. Histopathology

The pulmonary arteries in pulmonary arterial hypertension (PAH) are characterized

by medial hypertrophy and muscularization, intimal fibrosis, adventitial proliferation and

obliteration of small arteries. The medial hypertrophy is also the most commonly identified

lesion in pulmonary hypertension (PHT), and not restricted to PHT of any etiology, also is

considered to be the precursor to subsequent vascular alterations. Several types of intimal

lesions form part of the continuum of changes associated with plexogenic pulmonary

arteriopathy, although this lesion is found in many cases with primary pulmonary arterial

hypertension (PPH), are not pathognomonic, because they are also found in cases of severe

pulmonary hypertension associated with other diseases.

The genetics basis of familial PPH is unknown, but the clinical and pathological

features are the same as in sporadically occurring PPH; this form displays genetic

13

Page 14: anestesi umum

anticipation and an abnormal gender ratio at birth. This phenomenon, genetic anticipation,

suggests that the molecular basis of familial PPH may be trinucleotide-repeat expansion,

which is linked to unidentified genes of chromosome 2; but others investigators have

reported an association between the major histocompatibility complex and PPH. The

patients with this disease suggest that the coagulation system on the endothelial surface

may be activated as either a primary or a secondary process.

Vasoconstriction is a variable feature of PHT. Thromboxane A2 is both a potent

pulmonary vasoconstrictor and a procoagulant whereas prostacyclin has opposing effects,

and an imbalance between the releases of these two mediators could be involved in the

pathogenesis of the arteriopathy. Since the endothe lium produce an excessive production

of vasoconstrictors relative to vasodilators, and the smooth muscle cells are depolarized

and calcium-overloaded, which is due in part to reduced expression of voltage-gated

potassium channels (Kv). This causes vasoconstriction and may promote cell proliferation.

Even abnormal matrix metalloproteinase and elastase activity could also explain the

abnormal vascular tone, platelet activation, and remodeling in PPH.

2.5. Symptomatology

Hypertension is a major health problem, especially because it has no obvious

symptoms. Many people have hypertension without showing any obvious symptoms.

People with high blood pressure often do not feel sick. In fact, hypertension is often called

"the silent killer" because it may cause no symptoms at all for a long time. Your organs

and tissues can be damaged by hypertension without you knowing or feeling any 'external'

symptoms.

Most people with primary hypertension don't have any obvious symptoms at all,

also the possible symptoms of hypertension vary quite a lot from person to person. These

symptoms could also be symptoms of other health problems, however here are a few of the

more common symptoms of hypertension to look out for.

1. Chronic headaches

2. Dizziness or Vertigo

3. Blurry or double vision.

4. Drowsiness

14

Page 15: anestesi umum

5. Nausea

6. Shortness of breath

7. Heart palpitations

8. Fatigue - general tiredness

9. A flushed face

10. Nosebleeds

11. A strong need to urinate often (especially during the night)

12. Tinnitus (a ringing or buzzing in the ears)

13. Chest pain or pressure

14. Dizzy spells and fainting

15. Ankle or leg swelling (edema)

16. Bloating

2.6. Diagnosis

Because hypertension doesn't cause symptoms, it is important to have blood

pressure checked regularly. Blood pressure is measured with an instrument called a

sphygmomanometer. A cloth-covered rubber cuff is wrapped around the upper arm and

inflated. When the cuff is inflated, an artery in the arm is squeezed to momentarily stop the

flow of blood. Then, the air is let out of the cuff while a stethoscope placed over the artery

is used to detect the sound of the blood spurting back through the artery. This first sound is

the systolic pressure, the pressure when the heart beats. The last sound heard as the rest of

the air is released is the diastolic pressure, the pressure between heart beats. Both sounds

are recorded on the mercury gauge on the sphygmomanometer.

Normal blood pressure is defined by a range of values. Blood pressure lower than

120/80 mm Hg is considered normal. A number of factors such as pain, stress or anxiety

can cause a temporary increase in blood pressure. For this reason, hypertension is not

diagnosed on one high blood pressure reading. If a blood pressure reading is 120/80 or

higher for the first time, the physician will have the person return for another blood

pressure check. Diagnosis of hypertension usually is made based on two or more readings

15

Page 16: anestesi umum

after the first visit.

Systolic hypertension of the elderly is common and is diagnosed when the diastolic

pressure is normal or low, but the systolic is elevated, e.g.170/70 mm Hg. This condition

usually co-exists with hardening of the arteries (atherosclerosis).

Blood pressure measurements are classified in stages, according to severity:

- normal blood pressure: less than less than 120/80 mm Hg

- pre-hypertension: 120-129/80-89 mm Hg

- Stage 1 hypertension: 140-159/90-99 mm Hg

- Stage 2 hypertension: at or greater than 160-179/100-109 mm Hg

A typical physical examination to evaluate hypertension includes:

- medical and family history

- physical examination

- ophthalmoscopy: Examination of the blood vessels in the eye

- chest x ray

- electrocardiograph (ECG)

- blood and urine tests.

The medical and family history help the physician determine if the patient has any

conditions or disorders that might contribute to or cause the hypertension. A family history

of hypertension might suggest a genetic predisposition for hypertension.

The physical exam may include several blood pressure readings at different times

and in different positions. The physician uses a stethoscope to listen to sounds made by the

heart and blood flowing through the arteries. The pulse, reflexes, and height and weight are

checked and recorded. Internal organs are palpated, or felt, to determine if they are

enlarged.

Because hypertension can cause damage to the blood vessels in the eyes, the eyes

16

Page 17: anestesi umum

may be checked with a instrument called an ophthalmoscope. The physician will look for

thickening, narrowing, or hemorrhages in the blood vessels. A chest x ray can detect an

enlarged heart, other vascular (heart) abnormalities, or lung disease. An electrocardiogram

(ECG) measures the electrical activity of the heart. It can detect if the heart muscle is

enlarged and if there is damage to the heart muscle from blocked arteries. Urine and blood

tests may be done to evaluate health and to detect the presence of disorders that might

cause hypertension.

2.7. Therapy

There is no cure for primary hypertension, but blood pressure can almost always be

lowered with the correct treatment. The goal of treatment is to lower blood pressure to

levels that will prevent heart disease and other complications of hypertension. In secondary

hypertension, the disease that is responsible for the hypertension is treated in addition to

the hypertension itself. Successful treatment of the underlying disorder may cure the

secondary hypertension.

Patients whose blood pressure falls into the Stage 1 hypertension range may be

advised to take antihypertensive medication. Numerous drugs have been developed to treat

hypertension. The choice of medication will depend on the stage of hypertension, side

effects, other medical conditions the patient may have, and other medicines the patient is

taking.

Treatment with a single medicine fails to lower blood pressure enough, a different

medicine may be tried or another medicine may be added to the first. Patients with more

severe hypertension may initially be given a combination of medicines to control their

hypertension. Combining antihypertensive medicines with different types of action often

controls blood pressure with smaller doses of each drug than would be needed for just one.

Diuretics help the kidneys eliminate excess salt and water from the body's tissues

and the blood. This helps reduce the swelling caused by fluid buildup in the tissues. The

reduction of fluid dilates the walls of arteries and lowers blood pressure. New guidelines

released in 2003 suggest diuretics as the first drug of choice for most patients with high

blood pressure and as part of any multi-drug combination.

17

Page 18: anestesi umum

Beta-blockers lower blood pressure by acting on the nervous system to slow the

heart rate and reduce the force of the heart's contraction. They are used with caution in

patients with heart failure, asthma, diabetes, or circulation problems in the hands and feet.

Calcium channel blockers block the entry of calcium into muscle cells in artery

walls. Muscle cells need calcium to constrict, so reducing their calcium keeps them more

relaxed and lowers blood pressure.

ACE inhibitors block the production of substances that constrict blood vessels.

They also help reduce the build-up of water and salt in the tissues. They often are given to

patients with heart failure, kidney disease, or diabetes. ACE inhibitors may be used

together with diuretics.

Alpha-blockers act on the nervous system to dilate arteries and reduce the force of

the heart's contractions. Alpha-beta blockers combine the actions of alpha and beta

blockers. Vasodilators act directly on arteries to relax their walls so blood can move more

easily through them. They lower blood pressure rapidly and are injected in hypertensive

emergencies when patients have dangerously high blood pressure.

Peripheral acting adrenergic antagonists act on the nervous system to relax

arteries and reduce the force of the heart's contractions. They usually are prescribed

together with a diuretic. Peripheral acting adrenergic antagonists can cause slowed mental

function and lethargy. Centrally acting agonists also act on the nervous system to relax

arteries and slow the heart rate. They are usually used with other antihypertensive

medicines.

2.8. Treatment

Actual combinations of medications and lifestyle changes will vary from one

person to the next. Treatment to lower blood pressure may include changes in diet, getting

regular exercise, and taking antihypertensive medications. Patients falling into the pre-

hypertension range who don't have damage to the heart or kidneys often are advised to

make needed lifestyle changes only.

Lifestyle changes that may reduce blood pressure by about 5 to 10 mm Hg include:

18

Page 19: anestesi umum

- reducing salt intake

- reducing fat intake

- losing weight

- getting regular exercise

- quitting smoking

- reducing alcohol consumption

- managing stress

2.9. Complication

Excessive pressure on the artery walls can damage your vital organs. The higher

your blood pressure and the longer it goes uncontrolled, the greater the damage.

Uncontrolled high blood pressure can lead to:

1. Damage to your arteries. This can result in hardening and thickening of the

arteries (atherosclerosis), which can lead to a heart attack or other complications.

An enlarged, bulging blood vessel (aneurysm) also is possible.

2. Heart failure. To pump blood against the higher pressure in your vessels, your

heart muscle thickens. Eventually, the thickened muscle may have a hard time

pumping enough blood to meet your body's needs, which can lead to heart failure.

3. A blocked or ruptured blood vessel in your brain. This can lead to stroke.

4. Weakened and narrowed blood vessels in your kidneys. This can prevent these

organs from functioning normally.

5. Thickened, narrowed or torn blood vessels in the eyes. This can result in vision

loss.

6. Metabolic syndrome. This syndrome is a cluster of disorders of your body's

19

Page 20: anestesi umum

metabolism — including elevated waist circumference, high triglycerides, low

high-density lipoprotein (HDL), or "good," cholesterol, high blood pressure and

high insulin levels. If you have high blood pressure, you're more likely to have

other components of metabolic syndrome. The more components you have, the

greater your risk of developing diabetes, heart disease or stroke.

Uncontrolled high blood pressure also may affect your ability to think, remember and

learn. Cognitive impairment and dementia are more common in people who have high

blood pressure.

2.10. Prevention

Prevention of hypertension centers on avoiding or eliminating known risk factors.

Even persons at risk because of age, race, or sex or those who have an inherited risk can

lower their chance of developing hypertension.

The risk of developing hypertension can be reduced by making the same changes

recommended for treating hypertension:

- reducing salt intake

- reducing fat intake

- losing weight

- getting regular exercise

- quitting smoking

- reducing alcohol consumption

- managing stress

20

Page 21: anestesi umum

CHAPTER III

OBESITY

3.1. Definition

Obesity is an excess of body fat that frequently results in a significant

impairment of health. Obesity results when the size or number of fat cells in a person's

body increases. A normal-sized person has between 30 and 35 billion fat cells. When a

person gains weight, these fat cells first increase in size and later in number. One pound of

body fat represents about 3500 calories.

Obesity is a condition in which the natural energy reserve, stored in the fatty

tissue of humans and other mammals, exceeds healthy limits. It is commonly defined as a

body mass index (weight divided by height squared) of 30 kg/m2 or higher. Obesity is an

abnormal accumulation of body fat, usually 20 percent or more over an individual's ideal

body weight. Obesity is associated with an increased risk of illness, disability, and death.

3.2. Etiology

Obesity results when there is an imbalance between energy intake and energy

expenditure. In other words, you consume more calories than you expend in your daily

activities. Weight gained during certain critical periods of your life more commonly lead to

an increased number (as opposed to increased size) of fat cells and make obesity more

difficult to treat. These time periods are:

1. Between 12 and 18 months of age.

2. Between 12 and 16 years of age.

3. Adulthood when a person gains in excess of 60% of their ideal body weight.

21

Page 22: anestesi umum

4. Pregnancy.

During these periods, an excessive amount of weight gain causes an increased

number of fat cells. Once a fat cell is formed, you generally cannot get rid of it. However,

recent studies imply that use of certain medications can destroy fat cells and that a decrease

in the number of fat cells can occur if you maintain a lower body weight for a prolonged

period of time.

There are differences in people, and several factors that contribute to these

differences have been identified:

1. Age

As a general rule, as you grow older, your metabolic rate slows down and you

do not require as many calories to maintain your weight. People frequently state that they

eat the same and do the same activities as they did when they were 20 years old, but at 40,

are gaining weight. This will happen. Metabolism slows down with advancing age.

2. Gender

Gender is also an important factor. Males have a higher resting metabolic rate

than females, so males require more calories to maintain their body weight. This higher

resting metabolic rate is primarily due to the increased lean body mass (mainly muscle

tissue) males have compared to women. Additionally, when women enter menopause, their

metabolic rates decrease significantly. That is part of the reason why many women start

gaining weight after menopause.

3. Activity level

Active individuals require more calories than less active ones. Physical activity

tends to diminish appetite in obese individuals while increasing the body's ability to

preferentially metabolize fat as an energy source. It is believed that much of the increase in

obesity in the last 25 years has resulted from the decreased level of physical activity in

everyday life (such as emailing coworkers instead of walking over to their desks.

22

Page 23: anestesi umum

4. Body weight

Heavier people require more calories to maintain their body weights than

lighter ones. For example, a middle-aged male weighting 250 lbs. doing minimal amounts

of physical activity may require 2700 calories to maintain his body weight. If this person

goes on a 2000 calorie-per-day diet, he will lose weight. Eventually, however, even if he

stays with a 2000-calorie daily diet, his weight will stabilize because his metabolic rate

will gradually decrease. When this man reaches approximately 200 lbs., he will require

perhaps only about 2000 calories per day to maintain his new weight. This is a normal

process and takes place in all individuals.

5. Food preferences

High fat foods are obesity-promoting in animals and humans. In the last 25

years, the ready availability of high fat foods (such as, "fast foods"), combined with the

decreased calorie requirements from decreased physical activity, is felt to be the major

factor in the sharp rise in the prevalence of obesity. Thus, the current low carb, high fat diet

craze, which encourages intake of fatty meats instead of vegetables ("carbs"), will, in the

long run, result in an even a sharper rise in obesity and probably heart disease, as well.

6. Medications

Certain medications prescribed for inflammatory conditions, seizures, and

mental illness tend to increase appetite and may also decrease metabolic rate.

7. Hereditary factors affecting appetite and metabolism

Heredity is associated not only with obesity, but also with thinness. It most

closely correlates with the biological mother's weight. If the biological mother is heavy as

an adult, there is approximately a 75% chance that her children will be heavy. If the

biological mother is thin, there is also a 75% chance that her children will be thin. It is

related to metabolic processes inherited primarily from the biological mother. These

differences are independent of thyroid activity which, incidentally, is a relatively rare cause

of obesity.

23

Page 24: anestesi umum

3.3. Epidemiology

According to the Centers for Disease Control and Prevention (CDC)

Behavioral Risk Factor Surveillance System (BRFSS), self-reported prevalence of obesity

among US adults increased from 12% in 1991 to 18% in 1998. [8] Data from the 1988 to

1994 National Health and Nutrition Examination Survey (NHANES) suggested that 63%

of men and 55% of women were overweight. [9] More recent (1999) data from NHANES

IV found that obesity rates among adult Americans increased from 15% in 1980 to 27% in

1999. [10]

The magnitude of the increased prevalence of obesity in the US between

1991 and 1998 varies by region. It ranges from 31.9% in the mid-Atlantic to 67.2% in the

south Atlantic regions. [8] The increased prevalence also varies considerably by state

ranging from 11.3% in Delaware to 101.8% for Georgia. [8] In another survey, Missouri

ranked 2nd in overweight. [11] The magnitude of the increase is greatest in 18 to 29 year

olds (7.1% to 12.1%), those with some college education (10.6% to 17.8%), and those of

Hispanic ethnicity (11.6% to 20.8%). [8]

3.4. Symptomatology

The following are the most common symptoms that indicate a person is

obese. However, each person may experience symptoms differently. Symptoms may

include:

facial features often appear disproportionate

adiposity (fat cells) in the breast region in boys

large abdomen (white or purple marks are sometimes present)

in males, external genitals may appear disproportionately small

puberty may occur early

increased adiposity in the upper arms and thighs

genu valgum (knock kneed) is common

Arthritis (see arthritis entry) and other problems with bones and muscles, such as

lower back pain

Heartburn

24

Page 25: anestesi umum

High cholesterol levels

High blood pressure

Menstrual problems

Shortness of breath

Skin disorders

People who are obese often experience significant social pressure, stress,

and difficulties accomplishing developmental tasks. Psychologic disturbances are also very

common. The symptoms of obesity may resemble other conditions or medical problems.

3.5. Diagnosis

Tests to diagnose obesity include:

1. Body Mass Index (BMI) – Calculated by dividing your weight in kilograms by your height in meters squared. A BMI of 25 to 29.9 is considered overweight and 30 or higher is considered obese. (Source: Centers for Disease Control and Prevention and National Heart, Lung, and Blood Institute)

Classification of

ObesityBMI

Obesity

Class

Disease Risk (Relative to Normal Weight and Waist

Circumference)

Men < 40 in (102 cm)

Women < 35 in (88 cm)

Men > 40 in

Women > 35 in

Underweight<18.

5

Normal18.5-

24.9

Overweight25.0-

29.9Increased High

Obesity30.0-

34.9I High Very High

25

Page 26: anestesi umum

Obesity35.0-

39.9II Very High Very High

Extreme Obesity > 40 III Extremely High Extremely High

2. Waist Circumference, Saggital Diameter, and Waist-To-Hip Ratio – Simple

measurements that estimate the amount of fat deposited in the skin and inside the abdominal cavity. Waist circumferences that exceed 102 centimeters (40 inches) in men and 88 centimeters (35 inches) in women are associated with an increased risk of heart disease.

3. Skinfold Caliper – Most fat is deposited beneath the skin. This test measures fat just beneath the skin, but cannot measure fat accumulated inside the abdomen.

4. Water Displacement Tests – Fat floats; the rest of your body tissues sink. Determining how well you float provides an estimated ratio of fat to body mass.

5. Electrical Measurements – A couple of tests calculate your percentage of body fat by measuring the difference between the electrical characteristics of fat and other tissues in your body.

6. Blood tests – To rule out other medical conditions that may cause excess body weight,

such as a thyroid disorder, your doctor may order some blood tests

3.6. Therapy

Besides drugs and surgery, several fat binding products are available in the

market for weight loss. Proactol is a clinically proven weight loss product, now available

in the market. Proactol is highly recommended as the most effective therapy for obesity

because of its proven advantages and benefits.

The advantage of Proactol over other products is that it is the first weight

loss device product that is approved as a Medical Device Product (MDD 93/42/EEC). It

can come under the regulation medical device because it changes the mechanical process

of digesting food in the body. Proactol is safe, clinically proven and result oriented to

reduce fat.

Proactol meets the strict guidelines put forward by the Medicines and

Healthcare products Regulatory Agency (MHRA), USA. It is also the first ‘green’ weight

26

Page 27: anestesi umum

loss product that is free from allergens, artificial coloring, flavors, salt, gluten and

preservatives, certified by UK’s Vegetarian Society and certified organic by EcoCert.

Another major factor why we recommend Proactol for obesity therapy is

because it is clinically proven to bind more than 27 per cent fat intake and also reduce

calorie generated from the food consumed. It, however, retains the necessary nutrition

needed for a body. It also works as an appetite suppressant and thereby reduces cravings

for food. And the best part is there are no reported side effects. All of these claims are

backed by at least four published clinical studies.

3.7. Treatment

There are many treatment options for people who are suffering from

obesity. The best treatment is for an obese individual to decrease their calorie intake, to

decrease their fat consumption, to only use clinically proven obesity treatment product, to

become more active and to participate in physical manual labor. All of these factors form a

winning therapy in order to fight obesity. Many people will try weight loss pills, whether

prescribed or herbal, but they only work in conjunction with a healthy diet and vigorous

exercise program. People using these pills should be reminded of their serious side effects.

Obese people also have the choice to have surgery performed but this option is usually

only used in severe cases.

Once food intake is properly managed, an effort should be made to reduce

the weight of an obese person through physical labor and exercising. Routine physical

labor consumes extra fat cells therefore causing a noticeable reduction in weight. To add to

this endeavor, regular physical exercises would further the use of stored calories.

The most effective therapy to cure obesity is to change certain behavior

patterns. An obese individual should lower their food intake, consuming low calorie food,

use of a clinically proven weight loss product, participating in regular physical work and

exercise three times a week or more.

The intake of lesser food amounts and low calorie food at that will

automatically generate a smaller amount of food energy taken-in therefore causes a person

to be of a lower weight. Care should be taken that the diet is still nutritionally balanced. A

balance must be struck between adequate food and luxury dishes. The obese individual

must take great care in learning about food nutrition. A little amount of nutritional food

would make up a huge intake of junk food. Green vegetables play an important role in the

27

Page 28: anestesi umum

daily meal of an obese. Consumption of green vegetables in place of starchy food aids in

weight loss.

Alcohol should be avoided religiously. All attempts should be made to

avoid getting alcoholic fat cells in the tissues of the body. The overzealous use of

painkillers, sedatives, tranquilizers, anti-depressants and birth control pills should be

stopped if they can be. These drugs cause immense fat as they increase a person’s appetite

and the need to eat more to ease their increased hunger pains.

3.8. Complication

Obesity is a serious illness that can lead to many medical complications.

Unfortunately, it is relatively rare for physicians to treat obesity itself because it requires a

difficult, long-term process to treat effectively. However, treatment for its complications is

done at enormous cost.

1. Hypertension

The etiology of this increase in blood pressure appears to be related to substances

produced by adipose (fat) tissue and to the increase in the hormone insulin that

occurs with obesity. Obese individuals with hypertension should first be treated with

dietary methods in an attempt to reduce their weight. Rather a 10% reduction of

body weight combined with avoidance of excess salt intake can normalize blood

pressure and reduce or eliminate the need for blood pressure medications.

2. Diabetes

Obesity is the leading cause of diabetes. Type 2 of diabetes is almost always

associated with obesity and appears to be related to hormonal substances (cytokines)

produced by adipose (fat) tissue and to the increase amount of blood lipids (fats) that

occurs in diabetes. In the majority of obese individuals with diabetes, reducing body

weight by 10% can eliminate or reduce the need for oral medications or insulin

injections.

3. Elevated cholesterol

28

Page 29: anestesi umum

Elevated cholesterol (hypercholesterolemia) is commonly associated with obesity.

On average, every 10 lbs. of excess fat produces 10 mg. of cholesterol per day. In

other words, putting on 25 extra lbs. leads to the equivalent of taking in one extra

egg yolk per day. Cholesterol levels are determined by both genetics and diet. Two-

thirds of your cholesterol level is genetically determined, while the remaining one-

third is related to diet. Most people can successfully control their cholesterol by

reducing both their fat intake and weight.

4. Fatty Liver (NASH)

Fatty liver disease, more formally known as Non-Alcoholic Steato-Hepatitis

("NASH" - not "nash," the Yiddish word for eating sweets) is caused by excessive

fat deposition in the liver. Excess calorie consumption ("noshing" – the Yiddish

word), can lead to excess fat intake with the fat being stored not only in fat stores,

but also in the liver and other vital organs. This excess liver fat results in silent

inflammation, usually detected by abnormal liver function tests when a blood panel

is performed. If untreated, will go on to develop cirrhosis or liver failure during their

lifetime. Although some diabetic medications are used to treat this condition, the

most effective treatment is weight reduction and increase in physical activity.

5. Metabolic Syndrome (Syndrome X)

To be diagnosed with metabolic syndrome, you need three or more of the following

criteria:

- Waist circumference> 40 inches in men or 35 inches in women.

- Triglycerides > 150 mg/dl.

- HDL cholesterol< 40 mg/dl in men or <50 in women.

- Blood Pressure > 130/85 mm Hg.

- Glucose (fasting) >110 mg/dl.

29

Page 30: anestesi umum

The most effective treatment of metabolic syndrome is weight reduction; alternatively, the

individual conditions are treated with multiple medications and tremendous expense.

6. Cancer

Obesity also results in an increased risk of cancer. In females, there is up to a

threefold increase in the incidence of breast, uterine, cervical, and ovarian cancer.

The risk of endometrial cancer (cancer of the inside lining of the uterus) is up to

seven times higher. For men, there is an increased incidence of colon and prostate

cancer.

7. Degenerative arthritis

Obesity is frequently complicated by degenerative arthritis, the "wear-and-tear"

form, more formally known as osteoarthritis. Increased weight causes more wear

and tear on the joints. Adipose tissue also produces substances (cytokines) that

"destroy" the normal cartilage in joints. If a person loses weight, the wear and tear

gradually diminishes and the amount of cytokines released from adipose tissue

diminishes. The arthritic destruction of joints that has occurred over the years does

not disappear; however, the joint pain will generally diminish since there is less

stress and destruction of the joints.

8. Gallstones

Obesity is frequently complicated by gallstones. Approximately 25% of obese

individuals have gallstones, often resulting in surgery. The increase in cholesterol

that results from obesity is one of the major reasons for the increased incidence of

gallstones.

9. Heart attacks and strokes

There is an increased incidence of strokes and heart attacks in obese individuals.

This increase is both independent of and additive to the increased risk associated

with the elevated blood pressure, diabetes, and elevated cholesterol frequently

30

Page 31: anestesi umum

associated with obesity. This increased risk appears to be related to substances

produced by adipose (fat tissue) that make it easier for blood clots to form. Overall,

obesity results in premature death. As a general rule, for every pound

(approximately 1/2 kg.) over your ideal body weight, subtract one month from your

life expectancy.

10. Sleep disorders

As people gain weight, many complain that they feel tired all the time and may have

problems obtaining a restful sleep. Problems with sleep may be indicative of a

severe condition called Pickwickian Syndrome, or sleep apnea. For people with this

problem, it becomes progressively more difficult to breathe (especially at night) as

their weight increases. These people typically snore severely and have episodes

when they stop breathing completely, sometimes for up to one minute at a time.

During these apneic (not breathing) periods, heart rhythms may become very

irregular, which can lead to a fatal heart attack. People affected with sleep apnea

transiently awaken when they resume breathing. This may occur hundreds of times

per night, causing the afflicted individual to feel tired the next day. Sometimes,

these individuals will fall asleep while sitting in meetings or driving. Sleep apnea is

a very serious complication of obesity and requires professional medical attention.

The best method of treatment is weight reduction; however, other measures are

available to improve the breathing process and help prevent the heart irregularities

that frequently complicate this condition.

11. Depression

People with lesser degrees of obesity may also have problems sleeping. Sleep

disturbances are also associated with anxiety and depression. Depression is not just

feeling blue for a day, but is the result of actual chemical changes that take place in

the brain, causing profound episodes of sadness, crying, and loss of energy.

Depression is a medical condition that requires medical treatment. There are

effective non-addicting medications available if depression is complicating obesity.

3.9. Prevention

31

Page 32: anestesi umum

Primary prevention

While obesity has dual origins relating to both genetics and the

environment, these factors are inextricably linked. The genes provide the gun and the

environment pulls the trigger.

There is no doubt that the problem we face today is related to our modern

western environment. We live in a world of plentiful and attractive energy dense foods,

and a working and leisure environment that encourages sedentary behaviour. Solutions will

require involvement within our communities at many levels.  Solutions need to range from

legislation to protect our children from the bombardment of advertising from processed

food manufacturers, and provision of achievable physical activity guidelines for our

kindergartens and schools as an essential part of the daily activities, to local town planning

of our living environments to provide attractive, safe, user friendly areas for active leisure

and physical activity.

Secondary Prevention

Interventions to prevent or control disease are usually most effective, and

perhaps most cost effective, if delivered to a high-risk population. Diabetes prevention

studies have clearly demonstrated the value of such targeting.  Modest weight loss,

achieved through lifestyle change, has reduced the number of people with impaired fasting

glucose which leads to the development of type-2 diabetes.

CHAPTER 4

THE CORRELATION BETWEEN HIGH BLOOD PRESSURE AND OBESITY

32

Page 33: anestesi umum

FOR CHILDREN AT THE AGE OF 10 IN SOUTH JAKARTA IN 2005

4.1. Cases

The worldwide prevalence of obesity and its associated metabolic and

cardiovascular disorders has risen dramatically during the past two decades. Our objective

is to review the mechanisms that link obesity with hypertension and altered kidney

function. Current evidence suggests that excess weight gain may be responsible for 65-

75% of the risk for essential hypertension.

Being obese more than doubles the risk of developing raised blood pressure

(hypertension). Obesity research indicates that about 70 percent of obese men and women

suffer from hypertension. For example: the prevalence of hypertension in adults who are

not overweight (body mass index <25) is 14.9 percent for men and 15.2 percent for

women. In contrast, the prevalence of raised blood pressure levels in adults who are obese

(body mass index > 30) is 41.9 percent for men and 37.8 percent for women. The

prevalence of hypertension increases with the degree of obesity.

Morbid or severe clinical obesity is a significant contributor to

cardiovascular disease (inc. heart attacks and stroke) because it is associated with increased

prevalence of cardiovascular risk factors such as raised blood pressure, low levels of high

density lipoprotein (HDL) cholesterol, type 2 diabetes, hypertriglyceridemia,

hyperinsulinemia and insulin resistance. Hypertension means having: average systolic

blood pressure > 140 mm Hg, average diastolic > 90 mm Hg, or currently taking anti-

hypertensive medication.

4.2. Pathology

Excess weight gain is a major cause of increased blood pressure in most patients

with essential hypertension, and also greatly increases the risk for renal disease. Obesity

raises blood pressure by increasing renal tubular reabsorption, impairing pressure

natriuresis, causing volume expansion due to activation of the sympathetic nervous system

and renin-angiotensin system, and by physical compression of the kidneys, especially

when visceral obesity is present. The mechanisms of sympathetic nervous system

33

Page 34: anestesi umum

activation in obesity may be due, in part, to hyperleptinemia that stimulates the

hypothalamic pro-opiomelanocortin pathway. With prolonged obesity, there may be a

gradual loss of nephron function that worsens with time and exacerbates hypertension.

Weight reduction is an essential first step in the management of obesity hypertension and

renal disease. Special considerations for the obese patient, in addition to adequately

controlling the blood pressure, include correction of the metabolic abnormalities and

protection of the kidneys from further injury.

Many medical studies have shown that obesity presented an increase in the cardiac

output and the blood volume, and in the arterial resistance. In fact, obesity induces a high

secretion of insulin in trying to decrease the excessive sugar concentration in the blood.

This insulin secretion is very high compared to a non-obese subject.

Moreover, the insulin, secreted by the pancreas, is responsible for many

modifications in the body:

- It induces a thickening of the vessels which is responsible for an increase in

their rigidity, thus increasing the blood pressure;

- It increases the cardiac output, because the secretion of adrenalin is

increased;

- It induces the reabsorption of water and salt by the kidney, which increases

the blood volume and thus increases the blood pressure;

- Moreover, obesity is responsible for an over-sensitiveness to sodium, which

is known to increase the rigidity of the peripheral arteries.

After some time, the obese subject will develop a natural resistance to the insulin which

will lead his body to synthetize more insulin, thus generating a rise in the blood pressure

by the way of the mechanisms described above.

Excess weight gain accounts for as much as 65-75% of the risk for essential

hypertension and also greatly increases the risk for end stage renal disease (ESRD).

Obesity raises blood pressure by increasing renal tubular reabsorption, impairing pressure

natriuresis, and causing volume expansion due to activation of the sympathetic nervous

system (SNS) and renin-angiotensin aldosterone system (RAAS), and by physical

compression of the kidneys, especially when visceral obesity is present. The mechanisms

of SNS activation in obesity are still unclear but may be due, in part, to hyperleptinemia

34

Page 35: anestesi umum

that stimulates the hypothalamic pro-opiomelanocortin (POMC) pathway

Abnormal renal pressure natriuresis, due initially to increased renal tubular sodium

reabsorption, is a key factor linking obesity with hypertension. Obesity increases renal

sodium reabsorption by activating the renin-angiotensin and sympathetic nervous systems,

and by altering intrarenal physical forces. Adipose tissue functions as an endocrine organ,

secreting hormones/cytokines (e.g. leptin) that may activate the sympathetic nervous

system and alter kidney function. Excess visceral adipose tissue may physically compress

the kidneys, increasing intrarenal pressures and tubular reabsorption. Sustained obesity

eventually causes structural changes in the kidneys and loss of nephron function, further

increasing arterial pressure and leading to severe renal disease in some cases.

4.3. Diagnosis

The diagnosis of hypertension should be based on multiple BP measurements, taken

on separate occasions. Current definitions and classification of BP levels. Current

guidelines suggest that essential laboratory investigations should include: blood chemistry

for fasting glucose, total cholesterol, high-density lipase (HDL)-cholesterol, triglycerides,

urate, creatinine, sodium, potassium, haemoglobin and haematocrit, urinalysis and an

electrocardiogram.

4.4. Treatment

The primary goal of treatment of the patient with hypertension is to maximally

reduce the long-term total risk of cardiovascular morbidity and mortality. This requires

treatment of the raised BP and appropriate management of other risk factors and associated

clinical conditions.

The role of lifestyle changes

Weight reduction is of primary importance in obese hypertensive patients. Weight

loss is associated with significant reduction of BP and has beneficial effects on associated

risk factors. The relationship between change in BP and weight loss is relatively weak.

However, BP decrease is closely related to reduction in abdominal fat mass. The BP

lowering effect of weight reduction may be enhanced by simultaneous reduction in sodium

35

Page 36: anestesi umum

intake.

Even modest reduction in body weight can lead to a meaningfully reduction in renin-

angiotensin-aldosterone system activity in plasma and adipose tissue, which may

contribute to the BP decrease. Weight loss of 5% is associated with the reduction of

angiotensinogen levels by 27%, renin by 43%, aldosterone by 31%, angiotensin-converting

enzyme activity by 12%, and angiotensinogen expression by 20% in adipose tissue.

Obese hypertensive patients should also be advised to eat more fruit and vegetables. The

Dietary Approaches to Stop Hypertension (DASH) study has shown that this together with

an extra effect of a much lower-fat and saturated-fat diet, independent of weight loss,

lowers BP, particularly in hypertensive subjects. The hypotensive effect of the DASH diet

is most pronounced if combined with a reduction in salt intake. The BP lowering effect of

weight reduction may be further enhanced by simultaneous increase in physical exercise.

The results of recent meta-analysis evaluating benefits of aerobic exercise indicate that

physical exercise decreases

BP in both normotensive and hypertensive subjects. BP reduction is influenced by the

intensity of the endurance training and net weight change.

Use of anti-obesity drugs – orlistat and sibutramine

Treatment with orlistat results in both weight loss and weight loss maintenance. Meta-

analysis of the placebo controlled studies evaluating the effects of orlistat on BP show that

greater weight loss in patients treated with orlistat is associated with significantly greater

decrease in BP.

Treatment of obese patients with sibutramine can produce dose-dependent increases in BP

and heart rate, especially during initial treatment. However, a recent metaanalysis indicate

that sibutramine treatment is unlikely to elicit a critical increase in BP even in hypertensive

patients. The cardiovascular effects of the drug appear to

be related to the weight loss achieved: patients who lose 5% or more of initial body weight

have a reduction in BP. Sibutramine is not contraindicated in patients with

well-controlled hypertension. In a study that evaluated the effects of sibutramine 10 mg in

obese hypertensive patients, there was a similar decrease in BP in patients taking placebo

and patients taking sibutramine. The role of sibutamine in management of high-risk

36

Page 37: anestesi umum

patients is currently tested in the SCOUT (Sibutramine Cardiovascular Morbidity and

Mortality Outcome Study) trial.

CHAPTER V

CONCLUSION

Obesity appears to be the most important risk factor for the development of

hypertension. There is growing evidence that adipose tissue may be directly involved in the

pathogenesis of hypertension. Assessment of BP and target organ damage, which is crucial

for risk stratification, might be more difficult in obese hypertensives than in normal-weight

patients. Intensive lifestyle interventions can reduce weight and decrease BP and

37

Page 38: anestesi umum

cardiovascular risk in obese hypertensive patients. Current guidelines do not provide

specific recommendation for pharmacological management of the hypertensive patients

with obesity. However, several lines of evidence suggest that anti- hypertensive agents that

block the renin-angiotensin system may be especially beneficial in treating obese

hypertensive patients.

Despite considerable progress in understanding the pathophysiology of obesity,

there are still no specific guidelines for the treatment of obesity hypertension other than

weight reduction. Special considerations for obese hypertensive patients, in addition to

controlling blood pressure, are correcting the metabolic abnormalities and protecting the

kidneys from injury. This remains an important area for further research, especially in view

of the current 'epidemic' of obesity in most industrialized countries.

BIBLIOGRAPHY

1. Brown CD, Higgins M, Donato KA, Rohde FC, Garrison R, Obarzanek E, Ernst ND,

Horan M. Body mass index and the prevalence of hypertension and dyslipidemia. Obes

Res 2000; 8: 605–619.

2. Kuch B, Muscholl M, Luchner A, Doring A, Riegger GA, Schunkert H, Hense HW.

[Sex differences in the correlation between obesity and hypertension with left ventricular

mass and hypertrophy]. Z Kardiol 1996; 85: 334–342.

38

Page 39: anestesi umum

3. Filipiak B, Schneller H, Döring A, Härtel U, Hense HW, Stieber J, Keil U. Monica-

Projekt Augsburg. GSF-Bericht Hrsg. von GSF- Forschungszentrum 1993.

4. Canoy D, Luben R, Welch A, Bingham S, Wareham N, Day N, Khaw KT. Fat

distribution, body mass index and blood pressure in 22 090 men and women in the Norfolk

cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC-

Norfolk) study. J Hypertens 2004; 22: 2067–2074.

5. Okosun IS, Prewitt TE, Cooper RS. Abdominal obesity in the United States: prevalence

and attributable risk of hypertension. J Hum Hypertens 1999; 13: 425-430.

6. Kastarinen MJ, Nissinen AM, Vartiainen EA, Jousilahti PJ, Korhonen HJ, Puska PM,

Tuomilehto J. Blood pressure levels and obesity trends in hypertensive and normotensive

Finnish population from 1982 to 1997. J Hypertens 2000; 18: 255–262.

7. Kuch B, Muscholl M, Luchner A, Doring A, Riegger GA, Schunkert H, Hense HW.

Gender specific differences in left ventricular adaptation to obesity and hypertension. J

Hum Hypertens 1998; 12: 685–691.

8. Huang Z, Willett WC, Manson JE, Rosner B, Stampfer MJ, Speizer FE, Colditz GA.

Body weight, weight change, and risk for hypertension in women. Ann Intern Med 1998;

128: 81– 88.

9. Kannel WB, Brand N, Skinner JJ Jr, Dawber TR, McNamara PM. The relation of

adiposity to blood pressure and development of hypertension. The Framingham study. Ann

Intern Med 1967; 67: 48–59.

10. Julius S, Valentini M, Palatini P. Overweight and hypertension: a 2-way street?

Hypertension 2000; 35: 807–813. 11. Sharma AM. Adipose tissue: a mediator of

cardiovascular risk. Int J Obes Relat Metab Disord 2002; 26(Suppl. 4): S5–S7.

12. Scherrer U, Randin D, Tappy L, Vollenweider P, Jequier E, Nicod P. Body fat and

sympathetic nerve activity in healthy subjects. Circulation 1994; 89: 2634–2640.

39

Page 40: anestesi umum

13. Shek EW, Brands MW, Hall JE. Chronic leptin infusion increases arterial pressure.

Hypertension 1998; 31: 409–414.

14. Brook RD, Bard RL, Rubenfire M, Ridker PM, Rajagopalan S. Usefulness of visceral

obesity (waist/hip ratio) in predicting vascular endothelial function in healthy overweight

adults. Am J Cardiol 2001; 88: 1264–1269.

15. Wofford MR, Hall JE. Pathophysiology and treatment of obesity hypertension. Curr

Pharm Des 2004; 10: 3621–3637.

16. Hall JE. The kidney, hypertension, and obesity. Hypertension 2003; 41: 625–633.

17. Rahmouni K, Correia ML, Haynes WG, Mark AL. Obesity- associated hypertension:

new insights into mechanisms. Hypertension 2005; 45: 9–14.

19. Sharma AM, Engeli S, Pischon T. New developments in mechanisms of obesity-

induced hypertension: role of adipose tissue. Curr Hypertens Rep 2001; 3: 152–156.

40


Recommended